Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
RXRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.91B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.91 Billion |
|---|---|
| Enterprise Value | $1.45 Billion |
| Earnings per Share | $-1.44 |
| Beta | 1.03 |
| Outstanding Shares | 543,000,977 |
Return
| Return on Equity | -52.51% |
|---|---|
| Return on Assets | -38.93% |
| Return on Invested Capital | -46.05% |
Valuation & Multiples
| P/E Ratio | -3.91 |
|---|---|
| PEG | 14.68 |
| Price to Sales | - |
| Price to Book Ratio | 3.52 |
| Enterprise Value to Revenue | 21.28 |
| Enterprise Value to EBIT | -2.87 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS Estimate
$-0.22
Consensus analyst estimateRevenue Estimate
$14.81 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 24, 2027
EPS Estimate
$-0.21
Consensus analyst estimateRevenue Estimate
$7.83 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 53.25% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | 52,000▼ 98.38% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.36%▼ 67.39% |
|---|---|
| Total Invested | $29.91M▼ 97.77% |
| Investors Holding | 83▼ 278.00% |
About Recursion Pharmaceuticals Inc
218 employees
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...